Clinical Trials for Biosimilars Explained: Ultimate Guide to Design, Compliance, and Global Approvals Mastering Clinical Trials for Biosimilars: Compliance-Driven Guide for Regulatory Affairs Professionals Introduction to Clinical Trials for Biosimilars and Their Importance Clinical trials for biosimilars are designed to demonstrate that a biosimilar is highly similar to its reference product in terms of efficacy, safety, and immunogenicity. Unlike innovator biologics, biosimilars follow a stepwise development pathway, where extensive analytical and nonclinical studies are followed by targeted clinical trials. Agencies such as the FDA, EMA, and CDSCO mandate clinical data as a critical component of biosimilar approval dossiers. By 2025,…